NCT02915081

Brief Summary

The investigators hypothesize that subjects undergoing liver resection and who are exposed preoperatively to high illuminance blue spectrum light will exhibit reduced organ injury, specifically liver dysfunction, than subjects exposed to standard ambient white fluorescent light.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 10, 2016

Completed
16 days until next milestone

First Posted

Study publicly available on registry

September 26, 2016

Completed
3 months until next milestone

Study Start

First participant enrolled

January 1, 2017

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2018

Completed
Last Updated

April 5, 2019

Status Verified

April 1, 2019

Enrollment Period

2 years

First QC Date

September 10, 2016

Last Update Submit

April 3, 2019

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change from baseline creatinine concentration at 24 hours after surgery

    a serum marker of acute kidney injury

    preoperatively and 24 hours after surgery

  • Change from baseline alanine aminotransferase (ALT) concentration at 24 hours after surgery

    a serum marker of acute liver injury

    preoperatively and 24 hours after surgery

Secondary Outcomes (5)

  • Change in serum cytokine concentrations at 24 hours after surgery

    24 hours after surgery

  • Ventilator-free days

    for the duration of postoperative inpatient hospital stay up to 28 days

  • ICU length of stay

    for the duration of postoperative inpatient hospital stay up to 28 days

  • renal replacement therapy

    for the duration of postoperative inpatient hospital stay up to 28 days

  • Change in serum cytokine concentrations at 1 hour after surgery

    1 hours after surgery

Study Arms (2)

Blue light

EXPERIMENTAL

Subjects will be exposed to 24 hours of bright (1700 lux) blue (peak 442 nm) spectrum light the day prior to operative intervention and for the 24 hours after the operative intervention.

Other: Blue light

Ambient light

NO INTERVENTION

Subjects will be exposed preoperatively to the lighting conditions of their living environment and postoperatively to the standard, white fluorescent lighting environment of the hospital.

Interventions

Illumination: High illumination lighting will be instituted with a Day\*Light Classic Light (Uplift Technologies, Dartmouth, NS) Blue wavelength: Each subject will be fitted with blue filtered goggles (Lee Filters, Burbank, CA). These goggles ensure the transmission of a bright (1700 lux) blue (peak 442 nm) spectrum light when the subject is within 12 inches. Photoperiod: A 24-hour photoperiod will be used that commences at 0800 the morning prior to surgery and continues for 24 hours. To account for potential variability in the exposure of interest, each subject will complete a diary to catalogue duration and distance of light exposure. Postoperatively the same photoperiod will be instituted and continued for one 24 hour period.

Blue light

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age greater than 17 years
  • undergoing right or left hepatic lobectomy

You may not qualify if:

  • presence of acute traumatic brain injury
  • blindness
  • immunosuppression or immunocompromised condition

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania, 15213, United States

Location

MeSH Terms

Conditions

Acute Kidney InjuryInflammation

Interventions

Blue Light

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

LightElectromagnetic RadiationElectromagnetic PhenomenaMagnetic PhenomenaPhysical PhenomenaOptical PhenomenaRadiationRadiation, Nonionizing

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

September 10, 2016

First Posted

September 26, 2016

Study Start

January 1, 2017

Primary Completion

December 31, 2018

Study Completion

December 31, 2018

Last Updated

April 5, 2019

Record last verified: 2019-04

Locations